Close Menu

NEW YORK – Bio-Techne said Tuesday that its fiscal 2020 first quarter revenues rose 12 percent year over year, driven by growth in each of its business segments.

For the three months ended Sept. 30, the firm reported revenues of $183.2 million compared to $163.0 million in Q1 2019, topping analysts' average estimate of $179.4 million. 

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

Sponsored by

This webinar will provide a behind-the-scenes look at the collaborative development of a novel multiplex assay to speed detection of mosquito-borne illness in the clinical setting.